View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsQuanta 配当と自社株買い配当金 基準チェック /06主要情報n/a配当利回り-1,920.4%バイバック利回り総株主利回り-1,920.4%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Aug 17Quanta, Inc. announced delayed 10-Q filingOn 08/16/2022, Quanta, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 17Quanta, Inc. announced delayed 10-Q filingOn 05/16/2022, Quanta, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Mar 29Quanta, Inc. announced delayed annual 10-K filingOn 03/28/2022, Quanta, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Aug 14Quanta, Inc. announced delayed 10-Q filingOn 08/13/2021, Quanta, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 12Quanta, Inc. announced delayed 10-Q filingOn 05/11/2021, Quanta, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 02Quanta, Inc. announced delayed annual 10-K filingOn 03/31/2021, Quanta, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Dec 23Quanta, Inc. (OTCPK:QNTA) entered into an agreement to acquire 51% stake in Medolife International, Inc.Quanta, Inc. (OTCPK:QNTA) entered into an agreement to acquire 51% stake in Medolife International, Inc. on December 21, 2020. In exchange, Quanta will issue 9000 shares newly created Series B Convertible Preferred Stock. Arthur G. Mikaelian, Ph.D was appointed as a member of the Board of Directors of Quanta, Inc and was also appointed to serve as the Company’s Chief Executive Officer. The acquisition is subject to customary due diligence by both parties, and to the approval of Quanta, Inc. shareholders.お知らせ • Nov 19Quanta, Inc. Announces Change of CEOThe Directors of Quanta, Inc. announced that pursuant to the Company's Transition to a Holding Company, Phil Sands was previously appointed as a member of the Company's Board of Directors. Mr. Sands also appointed as the Company's Chief Executive Officer, with such appointment as CEO to be effective ten days following the mailing of a Schedule 14F Information Statement to the Company's Shareholders. The appointment of Mr. Sands as CEO, the Company has received and hereby accepts the resignation letter of Eric Rice from all officer positions with the Company, to be effective ten days following the mailing of the Schedule 14F Information Statement to the Company's Shareholders.お知らせ • Nov 14Quanta, Inc. Appoints Phil Sands as Member of the Board of DirectorsOn November 13, 2020, Mr. Phil Sands was appointed as a member of the Board of Directors of Quanta, Inc. Mr. Phil Sands, age 59, brings over 20 plus years of corporate executive experience, business development, project management, investment consultation, and B2B sales experience within Small Business and Corporate America. He has served in diverse companies with positions of Investment Consultant, Business Development Manager, Director of Investor Relations and Principal of small businesses. Mr. Sands has through collaboration worked with investment firms and helped developed strategies for public and private funding offerings, debt debenture offerings, help with Private Placements, balance sheet review and offer investment location consultation, client presentation, coaching, and access to market makers and broker dealers. Has worked with clients from all sectors with diverse back grounds on the OTC markets as well NASDAQ companies. Sectors range from alternative energy, technical, medical, manufacturing and more.お知らせ • Nov 13Quanta, Inc. announced delayed 10-Q filingOn 11/12/2020, Quanta, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Aug 15Quanta, Inc. announced delayed 10-Q filingOn 08/14/2020, Quanta, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.決済の安定と成長配当データの取得安定した配当: QNTAの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: QNTAの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Quanta 配当利回り対市場QNTA 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (QNTA)n/a市場下位25% (US)1.4%市場トップ25% (US)4.2%業界平均 (Pharmaceuticals)2.1%アナリスト予想 (QNTA) (最長3年)n/a注目すべき配当: QNTAは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: QNTAは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: QNTAの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: QNTAが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YUS 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2023/05/17 17:15終値2023/05/15 00:00収益2022/03/31年間収益2021/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Quanta, Inc. これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Aug 17Quanta, Inc. announced delayed 10-Q filingOn 08/16/2022, Quanta, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 17Quanta, Inc. announced delayed 10-Q filingOn 05/16/2022, Quanta, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Mar 29Quanta, Inc. announced delayed annual 10-K filingOn 03/28/2022, Quanta, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Aug 14Quanta, Inc. announced delayed 10-Q filingOn 08/13/2021, Quanta, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 12Quanta, Inc. announced delayed 10-Q filingOn 05/11/2021, Quanta, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 02Quanta, Inc. announced delayed annual 10-K filingOn 03/31/2021, Quanta, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Dec 23Quanta, Inc. (OTCPK:QNTA) entered into an agreement to acquire 51% stake in Medolife International, Inc.Quanta, Inc. (OTCPK:QNTA) entered into an agreement to acquire 51% stake in Medolife International, Inc. on December 21, 2020. In exchange, Quanta will issue 9000 shares newly created Series B Convertible Preferred Stock. Arthur G. Mikaelian, Ph.D was appointed as a member of the Board of Directors of Quanta, Inc and was also appointed to serve as the Company’s Chief Executive Officer. The acquisition is subject to customary due diligence by both parties, and to the approval of Quanta, Inc. shareholders.
お知らせ • Nov 19Quanta, Inc. Announces Change of CEOThe Directors of Quanta, Inc. announced that pursuant to the Company's Transition to a Holding Company, Phil Sands was previously appointed as a member of the Company's Board of Directors. Mr. Sands also appointed as the Company's Chief Executive Officer, with such appointment as CEO to be effective ten days following the mailing of a Schedule 14F Information Statement to the Company's Shareholders. The appointment of Mr. Sands as CEO, the Company has received and hereby accepts the resignation letter of Eric Rice from all officer positions with the Company, to be effective ten days following the mailing of the Schedule 14F Information Statement to the Company's Shareholders.
お知らせ • Nov 14Quanta, Inc. Appoints Phil Sands as Member of the Board of DirectorsOn November 13, 2020, Mr. Phil Sands was appointed as a member of the Board of Directors of Quanta, Inc. Mr. Phil Sands, age 59, brings over 20 plus years of corporate executive experience, business development, project management, investment consultation, and B2B sales experience within Small Business and Corporate America. He has served in diverse companies with positions of Investment Consultant, Business Development Manager, Director of Investor Relations and Principal of small businesses. Mr. Sands has through collaboration worked with investment firms and helped developed strategies for public and private funding offerings, debt debenture offerings, help with Private Placements, balance sheet review and offer investment location consultation, client presentation, coaching, and access to market makers and broker dealers. Has worked with clients from all sectors with diverse back grounds on the OTC markets as well NASDAQ companies. Sectors range from alternative energy, technical, medical, manufacturing and more.
お知らせ • Nov 13Quanta, Inc. announced delayed 10-Q filingOn 11/12/2020, Quanta, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Aug 15Quanta, Inc. announced delayed 10-Q filingOn 08/14/2020, Quanta, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.